KARLEE KROKOS: Open Payments
NPI 1528641479 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,009 in 110 payments from 20 companies in 2025. Trend: 2023 $1,063 · 2024 $1,226 · 2025 $2,009
Food & beverage: $2,009
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $238 |
| Amgen Inc. | 14 | $233 |
| PFIZER INC. | 10 | $201 |
| AstraZeneca Pharmaceuticals LP | 7 | $194 |
| Novo Nordisk Inc | 10 | $161 |
| ABBVIE INC. | 22 | $160 |
| Otsuka America Pharmaceutical, Inc. | 9 | $152 |
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| Vanda Pharmaceuticals Inc. | 4 | $102 |
| Corcept Therapeutics | 4 | $81 |
Products named: AIRSUPRA, REPATHA, LEQVIO, REXULTI, VRAYLAR, ZEPBOUND, FANAPT, MOUNJARO.
Industry payments across MI — which companies pay providers there.
